Agilent Technologies, Inc. provides core bio-analytical and electronic measurement solutions to the communications, electronics, life sciences, and chemical analysis industries. The Company offers electronic and bio-analytical measurement, semiconductor, and board testing.
ACX held its Scheme Meeting and the deal was overwhelmingly supported, as expected. The Federal Court has also now approved the scheme, so this deal is effectively over, and the stock has now stopped trading. Members will be paid the $7.80 (yielding a small 1.5% arbitrage) on 29 March.
We are glad you liked it
For your convenience, this will appear under your Saved articles in the top menu.